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Keliakian diagnostiikan kulmakivi on edelleen gluteenin aiheuttama limakalvovaurio ohutsuolessa. 
Vaurion aste arvioidaan yleensä käyttäen luokiteltuja asteikkoja, mutta nämä ovat usein liian 
epätarkkoja jättäen pieniä merkittäviä muutoksia huomiotta. Tämän vuoksi on tullut tarve kehittää 
validoituja jatkuvia muuttujia limakalvovaurion arviointiin.   
 
Arvioimme standardoidun toimintamenettelymme toimivuutta valikoidussa 93 potilaan ryhmässä. 
Näytteet sisälsivät eri asteisia limakalvovaurioita ja ne arvioitiin käyttäen jatkuvia muuttujia: 
nukkalisäke/kuopake-suhdetta ja valkosolutiheyttä. Kaksi akkreditoitua tutkijaa teki mittaukset 
sokkoutetusti. Tutkijan ja tutkijoiden välinen luotettavuus nukkalisäke/kuopake-suhteessa ja 
lymfosyyttitiheydessä tutkittiin Bland-Altmanin metodilla ja luokan sisäisellä korrelaatiolla. 
 
Molemmat tutkijat tunnistivat yhtenevästi palat, joita ei saanut toimintamenettelymme mukaan 
mitata. Bland-Altmanin-metodi ja luokan sisäinen korrelaatio osoittivat luotettavia tuloksia ja 
keskihajonnaksi saatiin tutkijan välisessä analyysissä 0,159 ja tutkijoiden välillä 0,227. 
Keskihajonnaksi CD3-positiivisessa valkosolutiheydessä saatiin tutkijan sisäisessä analyysissä 
16,5% ja tutkijoiden välisessä analyysissä 17,1%.  
 
Käytettäessä standardoitua toimintamenettelyämme saavutettiin luotettavia ja toistettavia tuloksia 
jatkuville limakalvovaurion mittareille. Kliinisesti merkittäviksi muuttoksiksi asetettiin 
keskihajonnan mukaisesti nukkalisäke/kuopake-suhteessa 0.4 ja CD3-positiivisessa  
valkosolutiheydessä 30%. 
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Abstract
Background: Assessment of the gluten-induced small-intestinal mucosal injury remains the cornerstone of celiac disease
diagnosis. Usually the injury is evaluated using grouped classifications (e.g. Marsh groups), but this is often too imprecise
and ignores minor but significant changes in the mucosa. Consequently, there is a need for validated continuous variables
in everyday practice and in academic and pharmacological research.
Methods: We studied the performance of our standard operating procedure (SOP) on 93 selected biopsy specimens from
adult celiac disease patients and non-celiac disease controls. The specimens, which comprised different grades of gluten-
induced mucosal injury, were evaluated by morphometric measurements. Specimens with tangential cutting resulting from
poorly oriented biopsies were included. Two accredited evaluators performed the measurements in blinded fashion. The
intraobserver and interobserver variations for villus height and crypt depth ratio (VH:CrD) and densities of intraepithelial
lymphocytes (IELs) were analyzed by the Bland-Altman method and intraclass correlation.
Results: Unevaluable biopsies according to our SOP were correctly identified. The intraobserver analysis of VH:CrD showed a
mean difference of 0.087 with limits of agreement from 20.398 to 0.224; the standard deviation (SD) was 0.159. The mean
difference in interobserver analysis was 0.070, limits of agreement 20.516 to 0.375, and SD 0.227. The intraclass correlation
coefficient in intraobserver variation was 0.983 and that in interobserver variation 0.978. CD3+ IEL density countings in the
paraffin-embedded and frozen biopsies showed SDs of 17.1% and 16.5%; the intraclass correlation coefficients were 0.961
and 0.956, respectively.
Conclusions: Using our SOP, quantitative, reliable and reproducible morphometric results can be obtained on duodenal
biopsy specimens with different grades of gluten-induced injury. Clinically significant changes were defined according to
the error margins (2SD) of the analyses in VH:CrD as 0.4 and in CD3+-stained IELs as 30%.
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Introduction
In celiac disease the characteristic gluten-induced small-
intestinal mucosal injury develops gradually [1,2]. The spectrum
of mucosal changes contains two separate measurable parameters,
inflammation reflected by intraepithelial lymphocytic infiltration
and morphological damage which includes villous atrophy and
crypt hyperplasia. The mucosal lesion is the gold standard for
diagnosing celiac disease and is present in patients both with and
without clinical symptoms or signs of the disease. Well-known
grouped classifications in histological assessment are one described
by Marsh and modified by Oberhuber and another produced by
Corazza and Villanacci [1,3,4].These classifications are practical
in clinical work, but allocation to specific groups may be
challenging and minor histologic changes are easily missed [4].
Such small but significant changes can be caused even by relatively
small amounts of gluten and are particularly important when the
clinical effectiveness of pharmacological therapies is evaluated.
Also noteworthy is that only a morphologically healed mucosa,
and not the disappearance of symptoms, is a prerequisite for the
long-term well-being of a patient [5]. The key issue is thus whether
a potential drug or vaccine is able to prevent or attenuate the
gluten-induced mucosal damage [6,7]. Optimally, histological
evaluation should be made with validated and reliable readout
tools [4]. Unfortunately, recent studies have shown poor
reproducibility when using the results of grouped classification as
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the primary outcome. Moreover, evaluators have given discrepant
results in borderline findings, which are diagnostically the most
critical part of the deterioration [8–10]. An important reason for
these diagnostic problems might be incorrect orientation of biopsy
specimens, leading to tangential cuttings and faulty interpretations
[11–14]. Hence, validated standard operating procedures (SOPs)
are needed to ensure reliable and reproducible results.
We here evaluated the quantitative morphological (villus height-
crypt depth ratio, VH:CrD) and inflammatory (density of
intraepithelial lymphocytes, IEL) variables used in the assessment
of different degrees of damage in small-intestinal mucosal biopsies.
The aim was to provide a standardized methodology and cut-off
values for significant gluten-induced changes in the small-intestinal
mucosa to be employed in routine clinical practice, and in
academic and pharmacological studies in celiac disease.
Materials and Methods
Study design and small-bowel mucosal specimens
The study was conducted in the University of Tampere and
Tampere University Hospital. The material comprised altogether
93 small-intestinal mucosal specimens from 72 patients, which
were obtained from the prospectively collected database and
biobank maintained by our study group. Altogether 16 specimens
were obtained from newly diagnosed untreated celiac disease
patients, 44 from patients on a gluten-free diet, 16 from patients
who underwent gluten challenge and 17 specimens from non-
celiac disease controls. The mean age of the celiac patients was 57
years (range 15–81) and 67% were women. The mean age of the
non-celiac controls was 50 years (range 21–73 and 59% of them
were women. The small-bowel biopsies were selected (see later) to
represent variable stages of mucosal injury ranging from
completely normal histology to overt mucosal atrophy and crypt
hyperplasia. Further, specimens with good (n= 81) or poor
orientation (n = 12) were included.
The forceps biopsy specimens were formalin-fixed and embed-
ded in paraffin and another set of biopsies from the same patient
were embedded in optimal cutting temperature compound, snap-
frozen and stored at 270uC until used. For morphometric
analyses, paraffin-embedded standard 2-mm-thick sections were
processed and stained with hematoxylin-eosin (HE) and additional
sections from the same biopsy block were stained with monoclonal
CD3 -specific antibody (CD3, Ab-2; Thermo Scientific, Waltham,
MA). The small-intestinal mucosal VH:CrD was evaluated from at
least three separate VH:CrD units by measuring villi lengths (mm)
and crypt depths (mm), and the result was given as the average of
the ratios. IEL densities were counted under light microscopy both
in HE-stained sections [15] and in sections where T lymphocytes
were stained with monoclonal CD3-specific antibodies [16]. At
least 300 epithelial cells were counted in a continuous length of the
epithelium, and results were expressed as number of IELs per 100
epithelial cells.
Frozen 5-mm-thick sections were processed and CD3+ IELs
stained with monoclonal antibody Leu-4 (Becton Dickinson, San
Jose, CA). The IELs were then counted with a 1006 flat-field
light-microscope objective throughout the surface epithelium; at
least 30 fields measuring 1.6 mm in epithelial length were counted
and the IEL density was expressed as cells/mm of epithelium [17].
The selected paraffin-embedded biopsy blocks comprised a wide
spectrum of different degrees of mucosal injury and VH:CrD and
density of CD3+ IELs were evaluated in parallel by two readers
(JT,OK). Also, one evaluator had prior to the present evaluation
studied and given results on all of these specimens (JT). The
specimens were chosen by an independent selector (MM) and all
measurements were made by the evaluators in blinded fashion
without knowing the results obtained by the other evaluator or the
clinical data of the patients. One evaluator (JT) studied and
reported results on the VH:CrD measurements and all IEL
countings, while the other (OK) evaluated only the VH:CrD and
IELs from CD3+-stained paraffin specimens.
Biopsy readout standard operating procedure
Our study group has adopted the morphometric small-intestinal
mucosal biopsy measurements, as already described by Kuitunen
and co-workers in 1982 [13], and subsequently formed the
currently used SOP for histological readouts. SOP includes
teaching technicians to obtain correctly oriented cuttings of biopsy
specimens for morphometric evaluation. A crucial step in the
procedure is that an accredited evaluator, besides producing
acceptable interobserver and intraobserver morphometric results,
be able to identify cases with an inadequate specimen and/or poor
biopsy orientation, where measurements of villus-crypt units are
not viable. It is essential that only biopsies in which the plane of
sectioning is perpendicular to the luminal surface be considered, as
judged by the fact that the crypts of Lieberkuhn are cut
longitudinally and not in cross sections [11]. In a case of poor
orientation resulting in tangential cuttings the evaluator asks for
recuttings until reliable morphological readouts can be obtained.
In IEL measurements the results are independent of biopsy
orientation and recutting of specimens is rarely needed.
Effect of tangentially cut sections on the evaluation of
villus height-crypt depth ratio
A case example from routine clinics illustrating the effect of
tangential sectioning and subsequent recutting on morphological
biopsy readouts is presented. To highlight the importance of
correct sectioning, another formalin-fixed and paraffin-embedded
biopsy specimen was cut twice so that the plane of sectioning was
both perpendicular and tangential to the luminal surface. These
latter biopsy slices were HE-stained and grouped in Marsh-
Oberhuber classes (0, 1, 2, 3a, 3b, and 3c) by five independent
pathologists who were blinded to each other’s results and to the
double cutting of the same biopsy block.
Further, a computerized 3D model was created to evaluate the
effect of different planes of sectioning on the morphological
readouts of the mucosa. First, computerized blocks were made
representing small-intestinal mucosa in three different stages of
morphological injury and sections of these blocks then cut in such
a way that the plane of sectioning was both perpendicular and
tangential to the luminal surface. The computer modelling
program used was Autodesk Inventor 2008 (Autodesk, San Rafael,
CA).
Statistics
Intraobserver and interobserver variations were analysed by the
Bland-Altman method, linear regression analyses and intraclass
correlation coefficients (ICC) [18,19]. In the Bland-Altman
method, the differences between two quantitative measurements
are plotted against the averages of the two measurements, and the
results reported as the mean difference between the two
measurements and limits of agreement, which are defined as the
mean difference plus and minus twice the standard deviation of
the differences. Twice the standard deviation was used as margin
of error and a change exceeding this would thus be considered
clinically significant. In the Bland-Altman plot, the x axis shows
the mean of the results of the two measurements and the y axis
represents the absolute difference between the two measurements.
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When there is an increase in the variability of the differences as the
magnitude of the measurements increases, differences on the y axis
are recommended to be expressed as percentages of the values on
the axis (i.e. proportionally to the magnitude of the measurements)
[20]. Inter-method agreement was assessed with ICC. Quantita-
tive data were expressed as number of subjects (n), mean and
ranges.
Ethics
The patient recruitment and sample collection were approved
by the Ethics Committee of Tampere University Hospital and all
patients gave written informed consent.
Results
All 12 preselected biopsy specimens with tangential cuttings
rendering them unacceptable for VH:CrD analyses were correctly
identified by both study evaluators. The villus heights in the
remaining 81 specimens with proper orientation ranged from
1 mm to 595 mm and the crypt depths from 152 mm to 535 mm.
The subsequent mean value in VH:CrD was 1.39 (range 0.01–
3.23). In IEL countings, five HE-stained and five CD3+ paraffin
specimens and seven frozen specimens were excluded for technical
reasons resulting from insufficient amounts of epithelial cells. The
mean density of IELs in HE-stained specimens was 32 (range 8–
82) per 100 epithelial cells, in paraffin-embedded CD3+-stained
specimens 38 (range 9–103) per 100 epithelial cells and in CD3+-
stained frozen specimens 68 (range 12–190) cells/mm.
The Bland-Altman plots illustrating the agreement in intraob-
server and interobserver analyses in VH:CrD are shown in
Figures 1A and 1B and the corresponding numerical values in
Bland-Altman analyses are given in Table 1. In both intraobserver
and interobserver VH:CrD analyses, the mean differences in the
two measurement series compared were below 0.1, ensuring that
there was no marked systematic error in the study. Twice the
standard deviations, which represent the error range of the
measurements, were 0.318 in intraobserver and 0.454 in
interobserver analyses. The intraobserver and interobserver linear
regressions are shown in Figures 1C and 1D and the ICCs in
Table 1.
Bland-Altman statistics for the IEL countings are shown in
Table 2. In the intraobserver analyses of IEL countings, the twice
standard deviations representing the error ranges were 34.2% in
CD3+ paraffin, 33.0% in CD3+ frozen and 53.2% in HE stained
specimens.
The ICCs presented showed excellent agreement in the CD3+
stainings and the agreement was good in the HE countings
(Table 2). Additionally, the inter-method comparison between
frozen and paraffin-embedded CD3+ stainings showed an ICC of
0.679 (p,0.001). These IEL densities from different fixations and
stainings are mutually convertible and the following equations can
be obtained from the linear regression analyses: IEL densities of
paraffin-embedded CD3+ stainings (CD3Paraf) can be converted
to the conventional IEL densities in HE-stained paraffin specimens
(HEParaf) by the equation HEParaf = 0.619 * CD3Paraf + 8.061,
CD3+ frozen specimens (CD3Fro) to HE paraffin IEL density by
the equation HEParaf = 0.442 * CD3Fro +8.843 and IEL
densities from paraffin CD3+ to frozen CD3+ staining by the
equation CD3Fro = 1.466 * CD3Paraf +10.416.
The effect of incorrect biopsy orientation on histological
evaluation is shown in Figure 2. In routine clinics, the pathologist
interpreted the specimen in Figure 2A as normal mucosa, the
villous structures seen thus excluding celiac disease. However, due
to a high clinical suspicion of disease, biopsy re-evaluation was
asked for and recuttings performed by reason of original tangential
cutting as judged by biopsy cross-sectioning of the crypts. In these
reoriented specimens (Figure 2B), crypt hyperplasia with villous
atrophy compatible with celiac disease was obvious. To study
further this source of diagnostic error, our selected block from
another patient was evaluated by five independent pathologists. All
graded the tangential sectioning showing only cross-sections of
crypts but tall villi as representing Marsh 0–1 (Figure 2C). When
the same block had been cut perpendicular to the luminal surface,
the crypts were correspondingly cut longitudinally and the same
five pathologists graded the specimen as Marsh 3a–3b (Figure 2D).
In contrast, no marked differences can be seen in the IEL densities
in tangential and perpendicular cuttings (Figure 3).
In Figure 4, the computerized 3D-model demonstrates the effect
of differing cuttings, i.e. perpendicular and tangential, in the
evaluation of small-intestinal mucosal biopsy specimens. The
hallmark of tangential cuttings is circular cross-sectioning of the
mucosal crypts. Poor biopsy orientation results in incorrect
interpretation of VH:CrD and/or incorrect Marsh class.
Discussion
The present validation study demonstrated that quantitative
variables which measure separately gluten-induced morphological
(VH:CrD) and inflammatory (IEL density) changes are reliable
and reproducible. Morphometric variables can be utilized for
outcome measurements in both academic studies and forthcoming
drug trials in celiac disease. By following our SOP, we were able to
ensure strict limits of agreement in the Bland-Altman method and
excellent intraobserver and interobserver ICCs in VH:CrD in
biopsies with different grades of small-intestinal mucosal injury. It
is obvious that the forceps biopsy specimens obtained by
endoscopy are small and difficult to orientate correctly. The
cornerstone of our SOP has thus been to teach the accredited
evaluator when morphological variables are not amenable to
measurement. In all biopsy samples the sectioning of the crypts
should be inspected as a part of routine in order to avoid the
reading of tangential cuttings, wherein circular cross-sections of
crypts can be used as hallmark. In the present study, both
accredited evaluators were able to correctly identify the specimens
not suitable for subsequent morphological analyses. We believe
that our methodology for biopsy orientation and measurement of
morphology can be easily applied to any standard laboratory
settings.
VH:CrD measurement is a sensitive tool in detecting minor
changes in gluten consumption [8,21]. We have previously used a
change of 0.5 in VH:CrD as clinically relevant in assessing the
effect of a gluten-free diet in celiac disease patients and also during
gluten challenges [22]. The present findings would argue that this
value could be reduced, since the mean difference was below 0.1
and twice the standard deviation was only 0.318 in the
intraobserver Bland-Altman analysis. A cautious new cut-off value
of 0.4 could thus be assigned to represent a clinically relevant
difference between measurements. In the interobserver analysis
again, the limit needed to obtain 95% of subjects was 0.454,
indicating a slight observer-dependency in VH:CrD measure-
ments. We infer that small but significant gluten-induced mucosal
architectural changes can be reliably measured by morphometry.
The IEL densities in immunohistochemical CD3 stainings here
showed better limits of agreement in the intraobserver analyses
than the corresponding measurements in HE-stained specimens.
In contrast, the ICC between IEL measurements of the paraffin
and frozen specimens was good, and either one can be used for
reliable results. It should also be noted that the frozen sections are
Validation of Biopsy Readouts in Celiac Disease
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associated with better tissue preservation than the paraffin
associated specimens. However, frozen samples are more burden-
some due to specific technical requirements. We have used frozen
samples in academic research in order to measure, in addition to
CD3+ cells, the ab+ and cd+ T cell densities [16]. This also gives
an opportunity for internal staining control, as the density of all T
cells (CD3+) should be within the magnitude of the sum of ab+ and
cd+ T cell densities. In the present study, twice the standard
deviation was in the intraobserver analysis in frozen specimens
33.0% and in paraffin specimens 34.2%. These findings agree well
with previous studies in which a change of more than 30% in
lymphocyte count has been considered clinically relevant [20].
The limits of agreement in the absolute IEL density values were
wider in our study than those previously published, as we had
substantially higher mean lymphocyte densities overall [23]. We
thus provided values in percentages, as these are advocated when
Figure 1. Graphical illustrations of the reliability and reproducibility of villus height crypt depth ratio. Panels A and B show the Bland-
Altman plots of small-intestinal mucosal villus height crypt depth ratio and Panels C and D present the regression analyses for intraobserver and
interobserver analyses, respectively. The solid lines in panels A and B indicate the mean difference between the measurements and the dashed lines
correspond to the 95% limits of agreement.
doi:10.1371/journal.pone.0076163.g001
Table 1. Bland-Altman statistics with absolute values and intraclass correlation coeffients (ICC) for analysing agreement and
repeatability in small-bowel mucosal villus height crypt depth ratio (VH:CrD).
Mean difference (95% CI) Standard deviation Limits of agreement ICC
VH:CrD
Intraobserver 0.087 (0.051 to 0.121) 0.159 20.224 to 0.398 0.983
Interobserver 0.070 (0.020 to 0.121) 0.227 20.375 to 0.516 0.978
CI, confidence interval.
doi:10.1371/journal.pone.0076163.t001
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the variability in the measurements increases with higher IEL
densities [19]. These percentage values would thus be more
appropriate when assessing the effect of a gluten-free diet or novel
drugs in celiac disease.
Soon after the discovery of the gluten-induced detrimental effect
on the mucosal architecture in celiac disease it became clear that
great care should be taken in orienting specimens in order to
ensure representative vertical sections [11,24]. One of the main
reasons for missing a celiac disease diagnosis is incorrect biopsy
orientation, resulting in cross-sectioning of the crypts and thus loss
of evidence of crypt hyperplasia [10,25]. In contrast, the IEL
densities are mainly unaffected by the biopsy orientation as shown
here in Figure 3. The importance of having complete villus-crypt
units and longitudinally cut crypts is highlighted by the exempli-
fied biopsy cuttings seen in Figures 2 and 4. Further, when what
are in reality low merged and convoluted villous ridges are cut
tangentially the outcome is falsely normal-looking villi, as also seen
in our computerized model (Figure 4). It is also possible that a
normal mucosal architecture is falsely classified as celiac disease
when the cutting is almost fully tangential giving the biopsy
histological appearance of a ‘‘flat’’ lesion. Morphologically the
appearance would be similar to a tangentially cut true ‘‘flat’’ lesion
(Figure 4). False interpretation could occur especially if no cross-
sections of villi are present. These examples further demonstrate
Table 2. Bland-Altman statistics with absolute and percentage values and intraclass correlation coeffients (ICC) for analysing
agreement and repeatability in the density of intraepithelial lymphocytes (IELs) of paraffin CD3+, frozen CD3+ and hematoxylin-
eosin (HE) stained small-bowel mucosal biopsy specimens.
Mean difference (95% CI) Standard deviation Limits of agreement ICC
Paraffin CD3+ IELs/100 enterocytes
Intraobserver 0.961
absolute values 1.9 (0.7 to 3.2) 5.9 213.5 to 9.6
percentage values 5.1 (1.4 to 8.7) 17.1 238.6 to 28.4
Interobserver 0.842
absolute values 6.9 (4.4 to 9.4) 11.6 215.9 to 29.6
percentage values 24.1 (18.8 to 29.4) 24.7 224.3 to 72.5
Frozen CD3+ IELs/mm
Intraobserver 0.956
absolute values 2.0 (20.3 to 4.3) 10.9 219.4 to 23.4
percentage values 1.0 (22.5 to 4.5) 16.5 231.3 to 33.3
HE IELs/100 enterocytes
Intraobserver 0.854
absolute values 0.7 (22.6 to 1.3) 9.2 217.4 to 18.7
percentage values 8.1 (22.5 to 13.7) 26.6 244.0 to 60.2
CI, confidence interval.
doi:10.1371/journal.pone.0076163.t002
Figure 2. Two small-intestinal biopsy samples from routine clinics that show the importance of biopsy orientation in the
interpretation of specimens. Sectionings A and C are cut tangential and B and D perpendicular to the luminal surface showing the effect of
different orientation to the same small-intestinal mucosal biopsy block. The hallmark of tangential cutting is the cross-sectioning of the crypts while
in correct vertical cutting the crypts are cut longitudinally. In routine clinics, the tangentially cut sectioning A was interpreted as normal, and on re-
evaluation upon high clinical suspicion of celiac disease, the biopsy block was tilted and recut. The recut biopsy sample (B) reveals crypt hyperplasia
and villous atrophy compatible with celiac disease. To further highlight this potential source of diagnostic error, five independent pathologists were
asked to interpret another biopsy block with slices cut in different planes. All graded the tangential specimen C to be morphologically normal (Marsh
0–1) and the properly oriented specimen D to have villus atrophy and crypt hyperplasia (Marsh 3b or 3c).
doi:10.1371/journal.pone.0076163.g002
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that training of evaluators to correctly assess duodenal biopsy
cuttings is essential in the diagnosis of celiac disease. One
possibility to obtain good quality specimens is to orientate the
biopsy on acetate cellulose filter before cutting [26].
There has recently been debate as to what should be the
primary outcome when evaluating the effects of new treatments in
celiac disease [6,27]. Although there is already an established
mode of treatment, the gluten-free diet, there is an unmet need for
novel pharmacological alternatives. Up to 60% of celiac disease
patients may experience symptoms even on a strict gluten-free diet
[28]. Also, mucosal healing may be incomplete with injury
persisting in up to 60–80% of long-term treated patients in some
series [29,30]. Such lingering mucosal damage predisposes to
celiac disease-associated complications even if symptoms disappear
on a gluten-free diet [5,31]. As a result, biopsy readouts should be
favored in phase 2 clinical trials instead of self-perceived clinical
outcomes. It is evident that if a drug is able to inhibit the gluten-
induced mucosal injury similarly to a gluten-free diet, clinical
symptoms, signs of malabsorption and serum celiac disease-specific
antibodies will also disappear. In later phase 3 trials, well-validated
patient-related and non-invasive biomarker outcomes can be
favored as endpoints and biopsies are needed only in subgroups of
patients.
Conclusions
By following our SOP, excellent intraobserver and interobserver
agreement in detecting small but significant changes in the small-
intestinal mucosa can be achieved. The cut-off for clinically
significant morphological duodenal mucosal healing or gluten-
induced mucosal deterioration values as measured morphometri-
cally (VH:CrD) was set as 0.4. A 30% or higher change in T-cell
IEL densities, the marker of mucosal inflammation, can be
regarded as clinically significant. The present results confirmed
that proper orientation of biopsy specimens and recognition of
incorrect tangential cuttings is crucial in ensuring reliable and
reproducible histological results in celiac disease.
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the intraepithelial lymphocyte densities are 50 per 100 epithelial cells and 54 per 100 epithelial cells, respectively.
doi:10.1371/journal.pone.0076163.g003
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